CFA
AGN

Carroll Financial Associates’s Allergan plc AGN Stock Holding History

Carroll Financial Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,155
Closed -$204K – 1782
2020
Q1 		$204K Sell
1,155
-172
-13% -$32.4K 0.02% 300
2019
Q4 		$253K Sell
1,327
-103
-7% -$18.6K 0.02% 312
2019
Q3 		$240K Sell
1,430
-84
-6% -$13.7K 0.02% 324
2019
Q2 		$253K Sell
1,514
-161
-10% -$22.3K 0.02% 313
2019
Q1 		$245K Buy
1,675
+105
+7% +$15.2K 0.02% 293
2018
Q4 		$223K Sell
1,570
-129
-8% -$21.1K 0.02% 253
2018
Q3 		$323K Buy
1,699
+1,428
+527% +$262K 0.03% 221
2018
Q2 		$45K Hold
271
– – ﹤0.01% 517
2018
Q1 		$45K Hold
271
– – ﹤0.01% 511
2017
Q4 		$44K Sell
271
-60
-18% -$10.8K ﹤0.01% 514
2017
Q3 		$69K Hold
331
– – 0.01% 431
2017
Q2 		$80K Hold
331
– – 0.01% 416
2017
Q1 		$79K Sell
331
-126
-28% -$29.3K 0.01% 401
2016
Q4 		$95K Sell
457
-98
-18% -$20.3K 0.01% 353
2016
Q3 		$127K Buy
555
+226
+69% +$55.2K 0.02% 304
2016
Q2 		$76K Buy
329
+40
+14% +$9.22K 0.01% 376
2016
Q1 		$77K Buy
289
+20
+7% +$5.72K 0.01% 358
2015
Q4 		$84K Buy
269
+109
+68% +$32.5K 0.02% 318
2015
Q3 		$41K Hold
160
– – 0.01% 434
2015
Q2 		$49K Buy
160
+62
+63% +$18.5K 0.01% 383
2015
Q1 		$29K Buy
98
+34
+53% +$9.69K 0.01% 362
2014
Q4 		$17K Sell
64
-50
-44% -$12.5K 0.01% 418
2014
Q3 		$27K Buy
114
+54
+90% +$12.1K 0.01% 409
2014
Q2 		$13K Hold
60
– – ﹤0.01% 563
2014
Q1 		$12K Buy
+60
New +$11.9K ﹤0.01% 507
2013
Q4 		– Sell
-60
Closed -$8K – 918
2013
Q3 		$8K Sell
60
-340
-85% -$45.3K ﹤0.01% 566
2013
Q2 		$50K Buy
+400
New +$45.3K 0.02% 236

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Carroll Financial Associates's AGN Position: Q2 2020 in Review

Carroll Financial Associates sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,155 shares — an estimated $204K sold.

Carroll Financial Associates first reported a position in AGN in Q2 2013 and held it in 27 quarters. The position peaked at $323K in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Carroll Financial Associates reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Carroll Financial Associates sold 1,155 Allergan plc shares in Q2 2020, an estimated $204K.
  • Carroll Financial Associates first reported a position in Allergan plc in Q2 2013 and held it in 27 quarters.
  • Carroll Financial Associates's Allergan plc position peaked at $323K in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Carroll Financial Associates's 13F filing for Q2 2020, filed 9 Jul 2020.